Amber Cooper
About Amber Cooper
Amber Cooper is the CMO of Genomics + Lab Operations at Kindbody, specializing in fertility issues with a focus on improving IVF success and outcomes.
Amber Cooper: CMO, Genomics + Lab Operations at Kindbody
Amber Cooper is the Chief Medical Officer specializing in Genomics and Lab Operations at Kindbody. Before joining Kindbody, she was a founding physician and the Chief Medical Officer for the St. Louis region of Vios Fertility Institute. In her current role, she serves patients across multiple locations including St. Louis, MO, Chicago, IL, Detroit, MI, and Rogers, AR.
Amber Cooper's Education and Expertise in Fertility
Amber Cooper is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She completed her residency and fellowship at Washington University in St. Louis. With a deep understanding of both the personal and professional challenges of infertility, she has developed an expertise in areas such as IVF success, fertility preservation, ovarian dysfunction, ovarian reserve, aging, hysteroscopic surgery, genetics, and the environmental impact on ovarian aging and function.
Amber Cooper's Background in Fertility Studies and Research
Amber Cooper has led numerous clinical studies and has conducted research that has been covered in both local and national press. She is an established voice in her field, having spoken at various national and international forums on topics related to fertility. Her research interests include improving IVF outcomes, fertility preservation, and the impact of environmental factors on ovarian aging.
Amber Cooper: Published Works and Awards
Amber Cooper has received numerous awards throughout her career and has contributed as an author to several medical journals and textbooks. Her published works cover various important topics in reproductive endocrinology and infertility, enhancing the understanding and treatment approaches in these fields. Her contributions have been significant in advancing fertility medicine.